Wu Yilong: to promote medical reform Let the victim is "affordable" and "buy"

10:20:14 March 15, 2016

Source: xinhua

, vice President of the people's hospital of guangdong province, guangdong lung cancer institute professor Wu Yilong xinhua Yang nobelium was taken

Xinhuanet Beijing on March 15 (GongXiaoQian) lung cancer is one of the malignant tumor of morbidity and mortality rate is very high in China. Targeted drugs for lung cancer treatment in recent years, continuous innovation, prolonged the survival time of patients with lung cancer, but at the same time, still need to face the high cost of drug, treatment, patients with drug resistance occurs can not timely access to new drugs. Recently, the vice President of the people's hospital of guangdong province, guangdong lung cancer institute professor Wu Yilong said during an interview with xinhua, will have exactly curative effect of the medicine into the health care, for urgent clinical needs by accelerating drug approval of the review, is very important to improve the survival of tumor patients.

Accurate treatment Lung cancer is expected to become a chronic disease

It is understood that the incidence of lung cancer in China. Five years ago, is expected in about 600000 new cases. The latest statistics show that 2015 of 730000 new cases of lung cancer. "It has a lot to do with smoking and air pollution." Wu Yilong said, smoked more than a pack a day, and for lung cancer high-risk groups, those with a family history can be managed with regular low-dose spiral CT screening for early. "The clinical research proves, through the early low-dose spiral CT screening, can reduce 20% of lung cancer mortality".

When it comes to the treatment of lung cancer. Wu Yilong said that accurate treatment of lung cancer patients had significantly prolong survival time. Based on the genetic testing under the guidance of targeted therapy are part of the accurate treatment is very important. "Over the past decade, targeted drugs for lung cancer is a genetic changes will lung cancer patients with a median survival time (50% of the patients survive time) from more than a year up to three years or longer, and recently, for the research and development of targeted drugs and drug resistance to further improve the curative effect of patients with lung cancer."

"I think with the progress of medical technology, if a survival of patients with advanced lung cancer for over five years, then lung cancer could become a chronic disease in the future." Wu Yilong said.

Promote national negotiations To make health coverage effective treatment

However, for patients with targeted drugs cost is a big burden. Wu Yilong calculation way, "at present, the need to take a month of targeted drugs cost about fifteen thousand or so. If the patient eat a year, cost will be close to 200000".

To this, some companies will use the charity of chick model can reduce the patients' medical costs. Targeted drugs in patients with a few months later, can apply to the charity to get free drugs, but this does not solve the problem.

On "how to solve the patent medicine, imported drugs are expensive, people can't afford to use medicine", li bin, director of the national health development planning commission on March 8, twelfth session of the National People's Congress four conference said at a news conference, national health development planning commission chose five involved in cancer and other serious diseases treatment drugs as a negotiating pilot, these pilot drug price is more expensive patent medicine, the imported drugs. Through the national negotiations, drug prices drop can reach more than 50%. Ma xiaowei, deputy director of the national health development planning commission patent medicine once negotiations success, to put it on the related drug reimbursement directory, consider to lower drug prices.

When it comes to targeted drugs into health care, Wu Yilong advice, first of all, should listen to the opinions of the experts, more from the details, the deep design, reasonable control cost; Second, curative effect is medical insurance should be covered, people in urgent need of drugs, make health care use the most practical and where they are needed; Third, in the hope that countries will be more effective medicines into national negotiations.

Be badly in need of special drug approval need a quick introduction

According to Wu Yilong introduction, in 2014 by more than 100 consecutive patients, of which about 14% of the patients is to choose to buy foreign drugs, a small fraction of patients will choose to buy chemical raw materials powder. In 2015, the proportion rose to 31%.

"Purely from the data, in the face of the urgency, countries should draw lessons from foreign experience, to speed up the review for the specific drug approval." Wu Yilong said.

According to international experience, to innovative drugs, use the "wide into severe out" principles of examination and approval of a new drug as long as the pre-clinical safety no big problem, and soon be approved to enter clinical studies, but the enterprise must guarantee the safety and efficacy, drug can't approved. Wu Yilong said recently, American FDA will one target specific targeted drugs for lung cancer drug resistance mechanism in quick review channel, approval from the first clinical trials, only use for more than two and a half years of time. And another drug safety problems, although it is given a fast-track, but in the end is not approved. These are the result of the "wide into severe out".

It is understood that Mr. Ma in the 12th National People's Congress four conference press conference also said the country would consider for special drugs, open a green channel, a quick approval.

"The common people in urgent need of life-saving medicines quickly approved through the green channel, it is very accord with the international trend, more in line with the urgent treatment of patients with demand." Wu Yilong said.